nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activated protein C resistance – in the absence of factor V Leiden – and pregnancy
|
LINDQVIST, P. G. |
|
2006 |
4 |
2 |
p. 361-366 |
artikel |
2 |
A new method for assessment of an anti-5HT2A agent, sarpogrelate hydrochloride, on platelet aggregation
|
SATOH, K. |
|
2006 |
4 |
2 |
p. 479-481 |
artikel |
3 |
An intronic mutation within FGB (IVS1+2076 a→g) is associated with afibrinogenemia and recurrent transient ischemic attacks
|
DEAR, A. |
|
2006 |
4 |
2 |
p. 471-472 |
artikel |
4 |
Announcements
|
|
|
2006 |
4 |
2 |
p. 488 |
artikel |
5 |
Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin
|
YAMAMOTO, K. |
|
2006 |
4 |
2 |
p. 469-470 |
artikel |
6 |
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors
|
SANTAGOSTINO, E. |
|
2006 |
4 |
2 |
p. 367-371 |
artikel |
7 |
A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry
|
JIN, M. |
|
2006 |
4 |
2 |
p. 333-338 |
artikel |
8 |
Are B vitamins a risk factor for venous thromboembolism? Yes
|
EICHINGER, S. |
|
2006 |
4 |
2 |
p. 307-308 |
artikel |
9 |
Are B vitamins a risk factor for VTE? Perhaps
|
DEN HEIJER, M. |
|
2006 |
4 |
2 |
p. 309-311 |
artikel |
10 |
Association of increased fibrinogen concentration with impaired activation of anticoagulant protein C
|
DÍEZ, N. |
|
2006 |
4 |
2 |
p. 398-402 |
artikel |
11 |
Attack of the acronyms: TTP, VWF, ADAMTS-13 and SELDI-TOF-MS
|
AUTON, M. |
|
2006 |
4 |
2 |
p. 329-332 |
artikel |
12 |
Comparative RNA expression analyses from small-scale, single-donor platelet samples 1
|
HILLMANN, A. G. |
|
2006 |
4 |
2 |
p. 349-356 |
artikel |
13 |
ERK2 activation in arteriolar and venular murine thrombosis: platelet receptor GPIb vs. P2X1
|
OURY, C. |
|
2006 |
4 |
2 |
p. 443-452 |
artikel |
14 |
Factor V deficiency caused by a novel missense mutation, Ile417Thr, in the A2 domain
|
KLING, S. J. |
|
2006 |
4 |
2 |
p. 481-483 |
artikel |
15 |
Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect
|
CASTAMAN, G. |
|
2006 |
4 |
2 |
p. 357-360 |
artikel |
16 |
Forthcoming articles in the March issue
|
|
|
2006 |
4 |
2 |
p. xiv-xv |
artikel |
17 |
Function-blocking antithrombospondin-1 monoclonal antibodies
|
ANNIS, D. S. |
|
2006 |
4 |
2 |
p. 459-468 |
artikel |
18 |
Haplotypes of the fibrinogen gamma gene do not affect the risk of myocardial infarction
|
UITTE DE WILLIGE, S. |
|
2006 |
4 |
2 |
p. 474-476 |
artikel |
19 |
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|
MIYAKIS, S. |
|
2006 |
4 |
2 |
p. 295-306 |
artikel |
20 |
Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes
|
BOUKOUR, S. |
|
2006 |
4 |
2 |
p. 426-435 |
artikel |
21 |
Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates
|
GRUBER, A. |
|
2006 |
4 |
2 |
p. 392-397 |
artikel |
22 |
Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function
|
GAUR, M. |
|
2006 |
4 |
2 |
p. 436-442 |
artikel |
23 |
More on: aspirin resistance: position paper of the Working Group on Aspirin Resistance. Proposal for a Laboratory Test Guiding Algorithm
|
PULCINELLI, F. M. |
|
2006 |
4 |
2 |
p. 485-487 |
artikel |
24 |
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis
|
ZEE, R. Y. L. |
|
2006 |
4 |
2 |
p. 341-348 |
artikel |
25 |
Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor
|
WANG, X. |
|
2006 |
4 |
2 |
p. 403-410 |
artikel |
26 |
Nicotine induces tissue factor expression in cultured endothelial and smooth muscle cells
|
CIRILLO, P. |
|
2006 |
4 |
2 |
p. 453-458 |
artikel |
27 |
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function
|
HAYWARD, C. P. M. |
|
2006 |
4 |
2 |
p. 312-319 |
artikel |
28 |
Population variation in VKORC1 haplotype structure
|
MARSH, S. |
|
2006 |
4 |
2 |
p. 473-474 |
artikel |
29 |
Protease nexin-1: a regulator of vascular disease?
|
FERRONI, P. |
|
2006 |
4 |
2 |
p. 320-321 |
artikel |
30 |
Protein S multimers and monomers each have direct anticoagulant activity
|
HEEB, M. J. |
|
2006 |
4 |
2 |
p. 385-391 |
artikel |
31 |
Screening for bleeding disorders in women with menorrhagia using a platelet function analyzer
|
VEYRADIER, A. |
|
2006 |
4 |
2 |
p. 483-485 |
artikel |
32 |
Statins modulate expression of components of the plasminogen activator/plasmin system in human cardiac myocytes in vitro
|
DEMYANETS, S. |
|
2006 |
4 |
2 |
p. 476-479 |
artikel |
33 |
The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen
|
MORALES, L. D. |
|
2006 |
4 |
2 |
p. 417-425 |
artikel |
34 |
The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay
|
MATSUMOTO, T. |
|
2006 |
4 |
2 |
p. 377-384 |
artikel |
35 |
The serpin protease nexin-1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin
|
RICHARD, B. |
|
2006 |
4 |
2 |
p. 322-328 |
artikel |
36 |
Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease
|
BROPHY, D. F. |
|
2006 |
4 |
2 |
p. 372-376 |
artikel |
37 |
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans
|
SPIEL, A. O. |
|
2006 |
4 |
2 |
p. 411-416 |
artikel |
38 |
When is cardiovascular genomics delivering on its promise?
|
REITSMA, P. H. |
|
2006 |
4 |
2 |
p. 339-340 |
artikel |